Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Interleukin (IL)-17 is a recently described cytokine involved in the amplification of inflammatory responses and pathologies. A hallmark feature of IL-17 is its ability to induce expression of other cytokines and chemokines. In addition, IL-17 potently synergizes with tumor necrosis factor-alpha (TNFalpha) to up-regulate expression of many target genes, particularly IL-6. Despite the many observations of IL-17 signaling synergy observed to date, little is known about the molecular mechanisms that underlie this phenomenon. In the osteoblastic cell line MC-3T3, we have found that IL-17 and TNFalpha exhibit potent synergy in mediating IL-6 secretion. Here, we show that at least part of the functional cooperation between IL-17 and TNFalpha occurs at the level of IL-6 gene transcription. Both the NF-kappaB and CCAAT/enhancer-binding protein (C/EBP; NF-IL6) sites in the IL-6 promoter are important for cooperative gene expression, but NF-kappaB does not appear to be the direct target of the combined signal. Microarray analysis using the Affymetrix mouse MG-U74v2 chip identified C/EBPdelta as another gene target of combined IL-17- and TNFalpha-induced signaling. Because C/EBP family members are known to control IL-6, we examined whether enhanced C/EBPdelta expression is involved in the cooperative up-regulation of IL-6 by IL-17 and TNFalpha. Accordingly, we show that C/EBPdelta (or the related transcription factor C/EBPbeta) is essential for expression of IL-6. Moreover, overexpression of C/EBPdelta (and, to a lesser extent, C/EBPbeta) could substitute for the IL-17 signal at the level of IL-6 transcription. Thus, C/EBP family members, particularly C/EBPdelta, appear to be important for the functional cooperation between IL-17 and TNFalpha.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NF-κB subsequently upregulates expression of IκBζ and Bcl3, noncanonical members of the NF-κB family that in turn promote expression of various IL-17-NF-κB driven pro-inflammatory and anti-microbial genes”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
In the citing paper
“In addition to synergizing with strong NF-κB activators such as TNFα, lipopolysaccharide (LPS), IL-1β and lymphotoxin, IL-17 cooperates with IFNγ (activator of STAT1), IL-13 (STAT6), TGFβ (SMADs), fibroblast growth factor (FGF)2 (Ras:Raf) and a Candida albicans-derived pore-forming toxin from Candida albicans (c-Fos)”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
In the citing paper
“One of the best-studied examples of synergy is with TNFα”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
In the citing paper
“One curious aspect of IL-17 biology is that this cytokine is consistently a modest activator of signaling in vitro, regardless of the cell system analyzed”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
Citations
Cites
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526
A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., & Kishimoto, T. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08316.x · Cited by 1,482
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
CCAAT/enhancer-binding proteins: structure, function and regulation
RAMJI, D. P., & FOKA, P. (2002) · Biochemical Journal · doi:10.1042/bj20020508 · Cited by 1,400
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229
Human IL-17: a novel cytokine derived from T cells
Yao, Z., Painter, S. L., Fanslow, W. C., Ulrich, D., Macduff, B. M., Spriggs, M. K., & Armitage, R. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5483 · Cited by 1,021
Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
Research works printed but not linked: 2
- Libermann, 1990, Mol. Cell. Biol., 10, 2327
- Andoh, 2002, Int. J. Mol. Med., 10, 631
Cited by
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
“Furthermore, TNF-α and IL-6, which are both produced by Th17 cells, not only support Th17 cell development but also synergize with IL-17 to enhance the production of proinflammatory mediators (76).”
Lowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Self-citationStructure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
“Gel shift studies indicated that IL-17A activates p50 and p65 , which are components of the canonical NF-κB pathway”
Self-citationThe IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“One of the best-studied examples of synergy is with TNFα (Chiricozzi et al., 2011; Ruddy et al., 2004); consequently, bi-specific Abs are now in development for therapy (Fleischmann et al., 2017; Klunder et al., 2017; Kontermann and Brinkmann, 2015; Robert et al., 2017; Torres et al., 2016).”
BackgroundInfluentialSelf-citationTH17 cells in development: an updated view of their molecular identity and genetic programming
Dong, C. (2008) · Nature reviews. Immunology · doi:10.1038/nri2295 · Cited by 1,064
Sutton, C., Brereton, C., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,010
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities
Candelario-Jalil, E., Dijkhuizen, R. M., & Magnus, T. (2022) · Stroke · doi:10.1161/strokeaha.122.036946 · Cited by 953
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
Self-citationInterleukin 17 Promotes Angiotensin II–Induced Hypertension and Vascular Dysfunction
Madhur, M. S., Lob, H. E., McCann, L. A., Iwakura, Y., Blinder, Y., Guzik, T. J., & Harrison, D. G. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.145094 · Cited by 827
IL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
“Some data suggest that activation of C/EBP family members is part of the cooperative/synergistic activation of IL-17 with TNF-α [71].”
BackgroundInfluentialSelf-citationAfzali, B., Lombardi, G., Lechler, R. I., & Lord, G. M. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03356.x · Cited by 762
Regulation of inflammatory responses by IL-17F
Yang, X. O., Chang, S. H., Park, H., Nurieva, R., Shah, B., Acero, L., Wang, Y.-H., Schluns, K. S., Broaddus, R. R., Zhu, Z., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071978 · Cited by 739
Role of cytokines in inflammatory bowel disease
Sanchez-Muñoz, F., Dominguez-Lopez, A., & Yamamoto-Furusho, J. K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4280 · Cited by 699
Chiricozzi, A., Guttman-Yassky, E., Suárez-Fariñas, M., Nograles, K. E., Tian, S., Cardinale, I., Chimenti, S., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.340 · Cited by 686
Qian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1439 · Cited by 614
IL-17 family: Cytokines, receptors and signaling
Gu, C., Wu, L., & Li, X. (2013) · Cytokine · doi:10.1016/j.cyto.2013.07.022 · Cited by 595
Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex
Toy, D., Kugler, D., Wolfson, M., Bos, T. V., Gurgel, J., Derry, J., Tocker, J., & Peschon, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.36 · Cited by 570
“Costimulation with TNF, which is known to synergize with IL-17 (25), could not reverse this defect (data not shown).”
Ogura, H., Murakami, M., Okuyama, Y., Tsuruoka, M., Kitabayashi, C., Kanamoto, M., Nishihara, M., Iwakura, Y., & Hirano, T. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.018 · Cited by 564
“Moreover, TNF-a acts in concert with IL-17A to induce IL-6 production (Awane et al., 1999; Chen et al., 2003; Ruddy et al., 2004).”
BackgroundIL-17 receptor–based signaling and implications for disease
Li, X., Bechara, R., Zhao, J., McGeachy, M. J., & Gaffen, S. L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0514-y · Cited by 548
Self-citationKaymaz, K., & Beikler, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143394 · Cited by 534
“Furthermore, TNF and IL-1β can synergistically increase IL-6 production and contribute to further Th17 cell differentiation [36].”
BackgroundThe Role of IL-17 and related cytokines in inflammatory autoimmune diseases
Kuwabara, T., Ishikawa, F., Kondo, M., & Kakiuchi, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/3908061 · Cited by 519
“Since it displayed a high degree of homology with the HVS13 Herpes virus gene, it was thought to be a subtype of the cytotoxic T-lymphocyte-associated protein (CTLA) family of proteins and called CTLA-8 [10].”
BackgroundDiversification of T-helper-cell lineages: finding the family root of IL-17-producing cells
Dong, C. (2006) · Nature Reviews Immunology · doi:10.1038/nri1807 · Cited by 487
Interleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 475
Basic biology and role of interleukin‐17 in immunity and inflammation
Zenobia, C., & Hajishengallis, G. (2015) · Periodontology 2000 · doi:10.1111/prd.12083 · Cited by 470
“The figure was drawn based on information from several sources (18, 47, 131, 141).”
BackgroundMethodThe IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
“Inflammatory response can be enhanced when necessary by increasing the expression of IkBζ and C/EBP.(58) An inflammatory response that is too strong and prolonged will damage healthy tissues.”
BackgroundPathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokines
Fitch, E., Harper, E., Skorcheva, I., Kurtz, S. E., & Blauvelt, A. (2007) · Current Rheumatology Reports · doi:10.1007/s11926-007-0075-1 · Cited by 415
“In addition, IL-17A synergizes with TNF-α to enhance inflammation, causing the release of IL-6, TNF-α, and IL-1β [42].”
BackgroundPerivascular adipose tissue inflammation in vascular disease
Nosalski, R., & Guzik, T. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13705 · Cited by 398
“IL-17A, IFN-γ and IL-6 have a synergistic effect with TNF-α to modulate inflammatory responses (Ruddy et al., 2004).”
BackgroundAn overview of IL-17 function and signaling
Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.017 · Cited by 382
Self-citationYu, J. J., Ruddy, M. J., Wong, G. C., Sfintescu, C., Baker, P. J., Smith, J. B., Evans, R. T., & Gaffen, S. L. (2007) · Blood · doi:10.1182/blood-2005-09-010116 · Cited by 372
Self-citationRole of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
Schinocca, C., Rizzo, C., Fasano, S., Grasso, G., La Barbera, L., Ciccia, F., & Guggino, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637829 · Cited by 360
“IL-17 works in synergy with TNF-α causing release of the IL-6, TNF-α, and IL-1β, in order to amplify the multifaceted and complex inflammatory process (88).”
BackgroundInterleukin-17 and its expanding biological functions
Xu, S., & Cao, X. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.21 · Cited by 357
Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor
Chang, S. H., Park, H., & Dong, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600256200 · Cited by 356
Monin, L., & Gaffen, S. L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028522 · Cited by 339
Self-citationGaffen, S. L., & Hajishengallis, G. (2008) · Journal of Dental Research · doi:10.1177/154405910808700908 · Cited by 334
Self-citationThe Immunopathogenesis of Psoriasis
Kim, J., & Krueger, J. G. (2015) · Dermatologic Clinics · doi:10.1016/j.det.2014.09.002 · Cited by 331
Wang, X., Yang, L., Huang, F., Zhang, Q., Liu, S., Ma, L., & You, Z. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.02.006 · Cited by 324
“IL-17 and TNF-α have been shown to cooperate functionally to induce expression of down-stream genes [21].”
BackgroundIdentification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes
Shen, F., Hu, Z., Goswami, J., & Gaffen, S. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604597200 · Cited by 294
Self-citationRecent advances in the IL-17 cytokine family
Gaffen, S. L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.006 · Cited by 283
“Current Opinion in Immunology 2011, 23:613–619 NF-kB, IL-17 activates IkBz and C/EBP transcription factors (mainly C/EBPd and C/EBPb) [78], as well as MAPK and possibly PI3K [4].”
Self-citationNajjar, S., Najjar, A., Chong, D. J., Pramanik, B. K., Kirsch, C., Kuzniecky, R. I., Pacia, S. V., & Azhar, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01896-0 · Cited by 282
“, cyclooxygenase-2, prostaglandin E2, and nitric oxide) [49].”
BackgroundA novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses
Chang, S. H., & Dong, C. (2007) · Cell Research · doi:10.1038/cr.2007.35 · Cited by 280
Shen, F., Ruddy, M. J., Plamondon, P., & Gaffen, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904490 · Cited by 268
Self-citationIL-17 and Th17 Cells in Atherosclerosis: Subtle and Contextual Roles
Taleb, S., Tedgui, A., & Mallat, Z. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303567 · Cited by 260
Shen, F., & Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.013 · Cited by 256
“CCAAT/Enhancer binding proteins (C/EBP) In a microarray screen for IL-17 target genes, IL-17 was found to up-regulate expression of CCAAT/enhancer binding proteins, (C/EBP)-d and -b [72].”
BackgroundInfluentialSelf-citationFibroblast pathology in inflammatory diseases
Wei, K., Nguyen, H. N., & Brenner, M. B. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149538 · Cited by 236
“For example, TNF and IL-17A synergistically activate fibroblasts (70, 71).”
BackgroundMarzano, A. V., Fanoni, D., Antiga, E., Quaglino, P., Caproni, M., Crosti, C., Meroni, P. L., & Cugno, M. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12394 · Cited by 242
IL-17 family member cytokines: Regulation and function in innate immunity
Reynolds, J. M., Angkasekwinai, P., & Dong, C. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.002 · Cited by 235
“Moreover, other pro-inflammatory cytokines, such as tumor necrosis factor alpha (TNFα), have been shown to cooperate with IL-17 to synergistically enhance the inflammatory capacity of innate cells (31,32).”
BackgroundSignaling of interleukin-17 family cytokines in immunity and inflammation
Chang, S. H., & Dong, C. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2010.11.022 · Cited by 229
IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Zepp, J., Wu, L., & Li, X. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.007 · Cited by 224
Engineering cytokine therapeutics
Deckers, J., Anbergen, T., Hokke, A. M., de Dreu, A., Schrijver, D. P., de Bruin, K., Toner, Y. C., Beldman, T. J., Spangler, J. B., de Greef, T. F. A., et al. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00030-y · Cited by 214
Interleukin-17 and systemic lupus erythematosus: current concepts
Nalbandian, A., Crispín, J. C., & Tsokos, G. C. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03944.x · Cited by 216
Nguyen, H. N., Noss, E. H., Mizoguchi, F., Huppertz, C., Wei, K. S., Watts, G. F. M., & Brenner, M. B. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.004 · Cited by 209
“ELF3 and CEBPD TFs have previously been implicated in IL-6 expression in murine dendritic and osteoblastic cells (Kushwah et al., 2011; Ruddy et al., 2004).”
BackgroundRuddy, M. J., Shen, F., Smith, J. B., Sharma, A., & Gaffen, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0204065 · Cited by 206
Self-citationLink between chronic inflammation and human papillomavirus-induced carcinogenesis (Review)
FERNANDES, J. V., DE MEDEIROS FERNANDES, T. A. A., DE AZEVEDO, J. C. V., COBUCCI, R. N. O., DE CARVALHO, M. G. F., ANDRADE, V. S., & DE ARAÚJO, J. M. G. (2015) · Oncology Letters · doi:10.3892/ol.2015.2884 · Cited by 196
Patel, D. N., King, C. A., Bailey, S. R., Holt, J. W., Venkatachalam, K., Agrawal, A., Valente, A. J., & Chandrasekar, B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703250200 · Cited by 197
Marzano, A. V., Cugno, M., Trevisan, V, Fanoni, D., Venegoni, L., Berti, E., & Crosti, C. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04201.x · Cited by 190
IL-17 in obesity and adipogenesis
Ahmed, M., & Gaffen, S. L. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.005 · Cited by 185
“Furthermore, IL-6 is required for the differentiation of naïve CD4 T cells into the Th17 lineage (22, 23), and is a major downstream gene target of IL-17A (24, 25).”
Self-citationIL-17 mediates articular hypernociception in antigen-induced arthritis in mice
Pinto, L. G., Cunha, T. M., Vieira, S. M., Lemos, H. P., Verri, W. A., Cunha, F. Q., & Ferreira, S. H. (2010) · Pain · doi:10.1016/j.pain.2009.11.006 · Cited by 183
Cardiac fibroblasts mediate IL-17A–driven inflammatory dilated cardiomyopathy
Wu, L., Ong, S., Talor, M. V., Barin, J. G., Baldeviano, G. C., Kass, D. A., Bedja, D., Zhang, H., Sheikh, A., Margolick, J. B., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132126 · Cited by 181
“Previous studies suggested that TNF synergizes with IL17A by stabilizing mRNA of IL17A targets (Ruddy et al., 2004).”
BackgroundIL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
Chiricozzi, A., Nograles, K. E., Johnson-Huang, L. M., Fuentes-Duculan, J., Cardinale, I., Bonifacio, K. M., Gulati, N., Mitsui, H., Guttman-Yassky, E., Suárez-Fariñas, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090284 · Cited by 180
Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission
Abdulahad, W. H., Stegeman, C. A., Limburg, P. C., & Kallenberg, C. G. M. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23557 · Cited by 178
Zrioual, S., Ecochard, R., Tournadre, A., Lenief, V., Cazalis, M.-A., & Miossec, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801967 · Cited by 169
Liu, X. K., Lin, X., & Gaffen, S. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405764200 · Cited by 168
Self-citationMaitra, A., Shen, F., Hanel, W., Mossman, K., Tocker, J., Swart, D., & Gaffen, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611589104 · Cited by 165
Self-citationRole of IL-17 in Psoriasis and Psoriatic Arthritis
Raychaudhuri, S. P. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8307-1 · Cited by 160
“These results suggest that IL17 has some synergistic effect with IL-1 and TNF-α [82, 84, 85].”
BackgroundInterleukin-17A: The Key Cytokine in Neurodegenerative Diseases
Chen, J., Liu, X., & Zhong, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.566922 · Cited by 165
“NF-κB upregulates the expression of B cell lymphoma 3-encoded protein (Bcl3) and then, in turn, facilitates the expression of multiple IL-17-NF-κB-driven anti-microbial and proinflammatory genes (Ruddy et al., 2004; Karlsen et al., 2010).”
BackgroundSelf-citationArmstrong, A. W., Voyles, S. V., Armstrong, E. J., Fuller, E. N., & Rutledge, J. C. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01308.x · Cited by 152
Sheibanie, A. F., Khayrullina, T., Safadi, F. F., & Ganea, D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22794 · Cited by 151
IL-17 and the Th17 lineage in systemic lupus erythematosus
Garrett-Sinha, L. A., John, S., & Gaffen, S. L. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328304b6b5 · Cited by 150
Self-citationInterleukin‐17: A New Paradigm in Inflammation, Autoimmunity, and Therapy
Kramer, J. M., & Gaffen, S. L. (2007) · Journal of Periodontology · doi:10.1902/jop.2007.060392 · Cited by 147
Self-citationSAPHO Syndrome: Current Developments and Approaches to Clinical Treatment
Firinu, D., García-Larsen, V., Manconi, P. E., & Giacco, S. R. D. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0583-y · Cited by 147
Garg, A. V., Amatya, N., Chen, K., Cruz, J. A., Grover, P., Whibley, N., Conti, H. R., Hernandez Mir, G., Sirakova, T., Childs, E. C., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.021 · Cited by 145
“MCPIP1 Regulates Nfkbiz mRNA Stability IL-17 upregulates IL-6 expression by control of mRNA stability and by activating its proximal promoter (Ruddy et al., 2004).”
Self-citationTh17 cells and IL-17 A—Focus on immunopathogenesis and immunotherapeutics
van den Berg, W. B., & McInnes, I. B. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.04.006 · Cited by 155
“partly through enhanced stability of mRNA transcripts and partly through cooperative effects on C/EBP transcription factors and NFκB at target genes [37,41].”
BackgroundThe IL‐17 pathway as a major therapeutic target in autoimmune diseases
Hu, Y., Shen, F., Crellin, N. K., & Ouyang, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05825.x · Cited by 156
Liu, X., Ye, F., Xiong, H., Hu, D., Limb, G. A., Xie, T., Peng, L., Zhang, P., Wei, Y., Zhang, W., et al. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.08.040 · Cited by 142
“[21] M.”
BackgroundSelf-citationKoenders, M. I., Marijnissen, R. J., Devesa, I., Lubberts, E., Joosten, L. A. B., Roth, J., van Lent, P. L. E. M., van de Loo, F. A., & van den Berg, W. B. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30418 · Cited by 138
Zhu, S., Pan, W., Shi, P., Gao, H., Zhao, F., Song, X., Liu, Y., Zhao, L., Li, X., Shi, Y., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100703 · Cited by 138
“It has been reported that C/EBP- is responsible for the synergistic induction of IL-6 (Ruddy et al., 2004).”
Lindenstrøm, T., Woodworth, J. S., Dietrich, J., Aagaard, C., Andersen, P. L., & Agger, E. M. (2012) · Infection and Immunity · doi:10.1128/iai.00550-12 · Cited by 140
“TNF- and IL-17A coexpression has been reported previously and found to act in synergy by promoting IL-23p19 and IL-6 expression, the latter through synergistic activation of transcription factors belonging to the C/EBP family (19, 44).”
BackgroundGaffen, S. L., Kramer, J. M., Yu, J. J., & Shen, F. (2006) · Vitamins and hormones · doi:10.1016/s0083-6729(06)74010-9 · Cited by 151
Self-citationShin, J. H., Shin, D. W., & Noh, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.008 · Cited by 144
Importance of IL-10 Modulation by Probiotic Microorganisms in Gastrointestinal Inflammatory Diseases
de Moreno de LeBlanc, A., del Carmen, S., Zurita-Turk, M., Santos Rocha, C., van de Guchte, M., Azevedo, V., Miyoshi, A., & LeBlanc, J. G. (2011) · ISRN Gastroenterology · doi:10.5402/2011/892971 · Cited by 131
Zhang, Q., Yamaza, T., Kelly, A., Shi, S., Wang, S., Brown, J., Wang, L., French, S. W., Shi, S., & Le, A. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007798 · Cited by 138
IL-17 Receptor Signaling Inhibits C/EBPβ by Sequential Phosphorylation of the Regulatory 2 Domain
Shen, F., Li, N., Gade, P., Kalvakolanu, D. V., Weibley, T., Doble, B., Woodgett, J. R., Wood, T. D., & Gaffen, S. L. (2009) · Science Signaling · doi:10.1126/scisignal.2000066 · Cited by 131
“We and others have shown that IL-17 induces the rapid expression of C/EBPb, C/EBPd messenger RNA (mRNA), and protein (13, 16, 17), as well as the generation of nuclear complexes that bind to C/EBP-binding sites in vitro (15).”
BackgroundMethodSelf-citationYamazaki, S., Muta, T., Matsuo, S., & Takeshige, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409983200 · Cited by 128
The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling
Garg, A. V., Ahmed, M., Vallejo, A. N., Ma, A., & Gaffen, S. L. (2013) · Science Signaling · doi:10.1126/scisignal.2003699 · Cited by 128
“MAPK activation leads to AP-1 activation, and AP-1 binding sites are statistically overrepresented in the promoters of IL-17 target genes (50); however, at least for the Il6 promoter, the AP-1 binding site is dispensable for IL-17–induced activation (46).”
BackgroundMethodSelf-citationTh17 and Cognitive Impairment: Possible Mechanisms of Action
Cipollini, V., Anrather, J., Orzi, F., & Iadecola, C. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00095 · Cited by 149
“…et al. (2011) regarding naive lymphocytes from AD patients have demonstrated an increase of Th17 cytokines production, including IL-21, IL-6, and IL-23 and expression of Th17 transcription factor RORγt in AD patients compared to MCI subjects and healthy control subjects (Saresella et al., 2011).”
BackgroundRegulation and pro‐inflammatory function of interleukin‐17 family cytokines
Dong, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00709.x · Cited by 125
“Moreover, IL-17 also synergizes with tumor necrosis factor-a (TNF-a) in inflammatory regulation (12).”
BackgroundHo, A. W., Shen, F., Conti, H. R., Patel, N., Childs, E. E., Peterson, A. C., Hernández-Santos, N., Kolls, J. K., Kane, L. P., Ouyang, W., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903739 · Cited by 125
“3D) and produced IL-6 significantly in response to IL-17A alone and in combination with TNF-a (Fig.”
InfluentialSelf-citationMok, M. Y., Wu, H. J., Lo, Y., & Lau, C. S. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100293 · Cited by 125
Gaffen, S. L. (2004) · Arthritis Research · doi:10.1186/ar1444 · Cited by 131
Self-citationRegulation of CCL20 expression in astrocytes by IL‐6 and IL‐17
Meares, G. P., Ma, X., Qin, H., & Benveniste, E. N. (2012) · Glia · doi:10.1002/glia.22307 · Cited by 113
“The soluble receptor allows IL-6 to signal in a wide variety of cells in the absence of the membranebound receptor in a process termed IL-6 trans-signaling (Mackiewicz et al., 1992; Scheller et al., 2011; Taga et al., 1989).”
BackgroundSARS-CoV Regulates Immune Function-Related Gene Expression in Human Monocytic Cells
Hu, W., Yen, Y.-T., Singh, S., Kao, C.-L., & Wu-Hsieh, B. A. (2012) · Viral Immunology · doi:10.1089/vim.2011.0099 · Cited by 112
“A previous study demonstrated that C/EBP delta can substitute for IL-17 to induce neutrophil activation and accumulation (45).”
The Interplay among miRNAs, Major Cytokines, and Cancer-Related Inflammation
Chakraborty, C., Sharma, A. R., Sharma, G., & Lee, S. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.04.002 · Cited by 122
Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer
Brevi, A., Cogrossi, L. L., Grazia, G., Masciovecchio, D., Impellizzieri, D., Lacanfora, L., Grioni, M., & Bellone, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565470 · Cited by 121
IL-17 in Systemic Lupus Erythematosus
Crispín, J. C., & Tsokos, G. C. (2010) · BioMed Research International · doi:10.1155/2010/943254 · Cited by 115
Nuclear envelope rupture and NET formation is driven by PKCα‐mediated lamin B disassembly
Li, Y., Li, M., Weigel, B., Mall, M., Werth, V. P., & Liu, M. (2020) · EMBO Reports · doi:10.15252/embr.201948779 · Cited by 112
“Co-presence of IL-17A and TNF a on NETs may synergistically propagate inflammatory responses through different mechanisms (Ruddy et al , 2004; Liu et al , 2011; Griffin et al , 2012).”
IL-17RC: a partner in IL-17 signaling and beyond
Ho, A. W., & Gaffen, S. L. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0185-0 · Cited by 104
Self-citationNF-κB and Its Role in Checkpoint Control
Betzler, A. C., Theodoraki, M., Schuler, P. J., Döscher, J., Laban, S. A., Hoffmann, T. K., & Brunner, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113949 · Cited by 113
“Since it has been shown that TNFα and IL-17 cooperatively induce expression of downstream genes, Wang and colleagues investigated a possible synergism of TNFα and IL-17 to induce PD-L1 expression [55,72].”
Background
Metadata
- Authors
- Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L.
- Affiliations
- University at Buffalo, State University of New York (US)
- The University of Osaka (JP)
- Corresponding author
- Gaffen, Sarah L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 279
- Issue
- 4
- Pages
- 2559-2567
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2087851913
- Cited by
- 364
- References
- 54
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 15 · 2023: 10 · 2022: 20 · 2021: 24 · 2020: 14 · 2019: 15 · 2018: 19 · 2017: 21 · 2016: 14 · 2015: 20 · 2014: 22 · 2013: 13 · 2012: 18
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6134 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI49329, AI 07614, T32AI007614)
- National Institute of Dental and Craniofacial Research (DE14460, R03DE014460)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- IL-17, TNF-α, C/EBP family, C/EBPδ, C/EBPβ, cytokine synergy, NF-κB, IL-6 promoter, transcriptional regulation
- MeSH terms
- Animals, Cell Line, Drug Synergism, Osteoblasts, Tumor Necrosis Factor-alpha, Signal Transduction, Transcriptional Activation, Interleukin-6, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.